These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

918 related items for PubMed ID: 9818654

  • 21. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E, Glidden DV, Elder ME.
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [Abstract] [Full Text] [Related]

  • 22. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D, Mestanza M, Cabiedes J, Cabral AR.
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [Abstract] [Full Text] [Related]

  • 23. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
    Borodin AG, Baranov NG, Nasonov EL.
    Klin Med (Mosk); 2001 Aug; 79(2):49-51. PubMed ID: 11419087
    [Abstract] [Full Text] [Related]

  • 24. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J, Masuda Y, Iwatani Y, Kuratsune H, Watanabe Y, Suehisa E, Takano T, Hidaka Y, Kanakura Y.
    Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
    [Abstract] [Full Text] [Related]

  • 25. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN, Novikov AA, Reshetniak TM, Kliukvina HG, Reshetniak DV, Nasonov EL.
    Klin Med (Mosk); 2003 May; 81(9):25-31. PubMed ID: 14598587
    [Abstract] [Full Text] [Related]

  • 26. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Kumar S, Isenberg DA.
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [Abstract] [Full Text] [Related]

  • 27. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 28. Association of antimitochondrial antibodies type 5 and anti-beta 2 glycoprotein I antibodies in the antiphospholipid syndrome.
    Laperche S, Abuaf N, Meyer O, Carsique R, Deschamps A, Rajoely B, Johanet C, Homberg JC.
    J Rheumatol; 1994 Sep; 21(9):1678-83. PubMed ID: 7799349
    [Abstract] [Full Text] [Related]

  • 29. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS, Cho ML, Joo YS, Kim WU, Hong YS, Min JK, Lee SH, Park SH, Cho CS, Kim HY.
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [Abstract] [Full Text] [Related]

  • 30. [Clinical subsets and phospholipid-dependent anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome].
    Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Matsuura E, Ikeda Y.
    Rinsho Ketsueki; 1995 Oct; 36(10):1170-4. PubMed ID: 8531326
    [Abstract] [Full Text] [Related]

  • 31. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG, Smith SA.
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [Abstract] [Full Text] [Related]

  • 32. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K, Tsutsumi A, Atsumi T, Matsuura E, Kobayashi S, Hughes GR, Khamashta MA, Koike T.
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [Abstract] [Full Text] [Related]

  • 33. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 34. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Sep; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 35. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 36. Antiphospholipid antibodies in arterial thrombosis.
    Koike T.
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [Abstract] [Full Text] [Related]

  • 37. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 38. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus.
    Molina JF, Gutierrez-Ureña S, Molina J, Uribe O, Richards S, De Ceulaer C, Garcia C, Wilson WA, Gharavi AE, Espinoza LR.
    J Rheumatol; 1997 Feb; 24(2):291-6. PubMed ID: 9034985
    [Abstract] [Full Text] [Related]

  • 39. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Satoh A, Suzuki K, Takayama E, Kojima K, Hidaka T, Kawakami M, Matsumoto I, Ohsuzu F.
    J Rheumatol; 1999 Aug; 26(8):1715-20. PubMed ID: 10451067
    [Abstract] [Full Text] [Related]

  • 40. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.
    Cabral AR, Cabiedes J, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct; 22(10):1894-8. PubMed ID: 8991988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.